The Life Sciences Law Review – Edition 10: Chapter 2 Argentina
por Ana Andrés
THE LAW REVIEWS
The pharmaceutical industry continues to be a highly regulated sector that has a very important presence in Argentina. Its financial results are highly affected by the influence of agreements entered into with social security organizations – mainly the social security organization that covers retired people – and private health insurance companies and 2021 has been no exception to this. These organizations agree on covering a part of the price fixed for the sale of products in pharmacies. On their side, all pharmacies agree on selling the products with the agreed discounts. Despite the fact that these kinds of agreements continue to be in place, due to continuing renegotiations, there have been changes in the financial politics because public social security organizations are now calling for bids and joint purchases of certain products – mainly those related to oncologic and special treatment prognosis, which are usually the most expensive products…
Palabras clave: Derecho de la Salud · Life Sciences
Reproducido con el permiso de Law Business Research Ltd. Este artículo se publicó primero en febrero 2022. Para más información, por favor contactar a Nick.Barette@thelawreviews.co.uk
the-life-sciences-law-review-10-argentina.pdf
The Life Sciences Law Review - Edition 10: Chapter 2 Argentina